Fibrinogen Concentrates Global Market is Anticipated to Witness 8.5% GAGR Expansion Between 2019 and 2026
According to the report, the Fibrinogen Concentrates market is predicted to achieve USD 1,306 million by 2026. This report examines the status quo and projections of the global Fibrinogen Concentrates market and analyzes the Fibrinogen Concentrates market by manufacturer, type, application, and region. This report focuses on top manufacturers in North America, Europe, Japan, China, India, Southeast Asia, and other regions (Central and South America, Middle East and Africa).
Market Summary
Fibrinogen, also known as coagulation factor I, is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen deficiency is a rare bleeding disorder characterized by mild to severe form of bleeding. The three types for fibrinogen deficiencies are: afibrinogenemia, hypofibrogenemia, and dysfibrinogenemia. In severely bleeding patients, fibrinogen concentrate significantly improves whole blood clot firmness and reduces the postoperative transfusion requirements. Currently, fibrinogen concentrates are widely used instead of traditional sources of fibrinogen, such as fresh frozen plasma and cryoprecipitate.
It is estimated that the total market value of the Fibrinogen Concentrates global market is poised to reach USD 1,306 million in 2026 from USD 738 million in 2019, with a CAGR of 8.5%.
The Fibrinogen Concentrates market report covers the leading players in the market and analyzes their key strategies. Leading players in this market include:
CSL Behring
Baxter
Johnson & Johnson (Ethicon)
LFB Group
ProFibrix BV (Medicines Company)
Shanghai RAAS
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
Greencross
Shanghai XinXing Medical
The prominent market players maintain the competitive edge in the global market by making investments in the mergers and acquisitions and by increasing their product portfolio.
Get FREE Sample of Fibrinogen Concentrates Market Report at:
Facilitating and Limiting Factors:
Rising demand for fibrinogen concentrates, increase in the number of cases of bleeding disorders, and surge in availability of fibrinogen products are the key factors projected to propel the growth of the fibrinogen concentrates market. Rise in awareness and concerns pertaining to the health are also stimulate the market growth. Further, increase in investment in research and development (R&D) and large number of products under pipeline offer significant opportunities in the market. Yet, certain adverse reactions such as arterial thrombosis, chills, dyspnea, nausea, vomiting, and pulmonary embolism may pose a challenge to the market growth.
The global Fibrinogen Concentrates market is broadly divided based on type, application, and region:
By type - Human Fibrinogen Concentrates, Animal Fibrinogen Concentrates
By application - Congenital Fibrinogen Deficiency, Surgical Procedures (Trauma Patients, Cardiovascular Surgery Patients, PPH Patients, Plastic Surgery Patients)
By region - North America, Asia-Pacific, Europe, Latin America, Middle East, and Africa, Others
North America is the global market leader at a share of 36%. The Asia-Pacific is currently leading Europe with a share of 30% and 24%. North America is expected to maintain its dominant position during the forecast period. The market in the region is anticipated to receive more attention to the development of new therapies for rare thromboembolic disorders and ways to improve orphan drugs for the treatment of rare diseases. The United States is expected to account for the largest market share in North America, followed by Canada.
The fibrinogen concentrates market in Asia-Pacific is projected to be driven by rise in awareness about diagnosis & treatment of fibrinogen deficiencies & other rare diseases and increase in the number of clinical trials for rare diseases. In addition, Europe is likely to gain market share over the forecast period due to increase in the number of market players offering plasma derived fibrinogen and rise in adoption of new therapies in Germany, France, the U.K., and other countries in the European Union. The LFB Group has obtained three European marketing licenses in Germany, Denmark and Hungary, namely FIBCLOT, its human fibrinogen.
Purchase a copy of Fibrinogen Concentrates report at:
What Information does this report contain?
l The report covers the prediction and analysis of the global Fibrinogen Concentrates market at the global and regional levels.
l The report includes drivers and constraints that affect market growth.
l Discussed details about market opportunities
l The assessments for the regional market layout characteristics in the world.
l The report includes detailed company profiles for prominent market participants.
Audience:
Fibrinogen Concentrates manufacturers
Fibrinogen Concentrates traders, distributors, and suppliers
Raw material suppliers of Fibrinogen Concentrates
Fibrinogen Concentrates industry associations
Product managers, Fibrinogen Concentrates industry administrator, C-level executives of the industries
Healthcare organizations
Market Research and consulting firms
Small and Medium-sized Enterprises (SMEs)
Table of Content
1 Report Overview
1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of Fibrinogen Concentrates Market
…
2 Market Trends and Competitive Landscape
3 Segmentation of Fibrinogen Concentrates Market by Types
4 Segmentation of Fibrinogen Concentrates Market by End-Users
5 Market Analysis by Major Regions
6 Product Commodity of Fibrinogen Concentrates Market in Major Countries
7 North America Fibrinogen Concentrates Landscape Analysis
8 Europe Fibrinogen Concentrates Landscape Analysis
9 Asia Pacific Fibrinogen Concentrates Landscape Analysis
10 Latin America, Middle East & Africa Fibrinogen Concentrates Landscape Analysis
11 Major Players Profile
11.1 CSL Behring
11.1.1 CSL Behring Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Baxter
11.3 Johnson & Johnson (Ethicon)
11.4 LFB Group
11.5 ProFibrix BV (Medicines Company)
11.6 Shanghai RAAS
11.7 Jiangxi Boya Bio-Pharmaceutical
11.8 Hualan Biological Engineering
11.9 Harbin Pacific Biopharmaceutical
11.10 Greencross
11.11 Shanghai XinXing Medical
…
Ask for a discount at:
About US
Global Market Monitor is a company that provides comprehensive services and products to global clients. We regularly update new reports on the website, ensuring that our clients stay abreast of the latest trends in their industries.
We engage in a wide, diverse range of international businesses and have established a sound customer base with about 11,000 clients in over 102 countries and regions. Headquartered in the USA and with 6 global offices around the world, it is convenient for Global Market Monitor to get a global view for global clients.
We are always committed to deliver customized market research solutions with the highest quality. As an information service company, we are specialized in offering market intelligence services from more than 500 research institute, involving plenty of industries, companies, trends, market drivers and other strategic data. About 100 million statistics with tables, figures and datasets are easy to access. Reports provided by Global Market Monitor can reveal the interrelationship between industries and markets, so that our clients have a better understanding of the global economy, risk, opportunity and financial impact.
Contact:
Global Market Monitor
One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,
NY 11201, USA
Name: Rebecca Hall
Phone: + 1 (347) 467 7721
Email: info@globalmarketmonitor.com
Web Site: https://www.globalmarketmonitor.com
We provide more professional and intelligent market reports to complement your business decisions.
Chinese